Medical Weight Loss

Consultations offered at our two convenient locations in Los Angeles and Lancaster, CA or by virtual appointment.

Dr. Satey offers a comprehensive weight loss program featuring various medications tailored to help you achieve your weight loss goals effectively and safely.

Mounjaro® | Zepbound® | Tirzepatide

Mounjaro and Zepbound are once-weekly injectable medications. Both work by mimicking natural hormones involved in appetite regulation and metabolic control.

Mounjaro is FDA-approved for blood sugar management in adults with type 2 diabetes. Zepbound is FDA-approved specifically for chronic weight management in adults who are overweight or obese when used with a reduced-calorie diet and increased physical activity.

Many patients in medically supervised weight-loss programs may benefit from tirzepatide-based therapy when clinically appropriate.

  • Potential benefits may include:
  • Reduced appetite
  • Feeling full sooner
  • Support for steady weight reduction over time
  • Improved control over cravings and portion sizes

Tirzepatide works as a dual GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, helping regulate appetite, support blood-sugar control, and influence how the body uses fat. Compounded tirzepatide is not FDA-approved.

Individual results vary. All treatment is provided under medical supervision, with dosing and ongoing monitoring tailored to each patient’s needs, goals, and medical history.

Ozempic® | Semaglutide

Ozempic® is a prescription medication FDA-approved for improving blood sugar control in adults with type 2 diabetes. In clinical studies, semaglutide has also been shown to support weight reduction when combined with appropriate dietary and lifestyle changes. Ozempic® is administered as a once-weekly injection, which many patients find more convenient than daily dosing options.

  • Potential benefits may include:
  • Improved blood sugar control
  • Reduced appetite
  • Support for weight reduction over time

Overview of Semaglutide: Compounded semaglutide is not FDA-approved, but it may be considered when clinically appropriate or when commercial products are unavailable. Semaglutide works as a GLP-1 receptor agonist, helping regulate appetite, support glucose control, and influence metabolic pathways involved in weight loss.

Potential benefits may include:

  • Support for reduced food intake and improved satiety
  • Once-weekly injections

Individual results vary. All medications are prescribed only after medical evaluation, and ongoing monitoring is provided throughout treatment.

Wegovy® | Saxenda®

Saxenda® is a daily injectable medication that aids in weight loss by acting like a hormone that regulates appetite. It is designed for adults who are overweight or obese.

Benefits:

  • Daily dosage for steady weight management
  • Suppresses hunger
  • Helps in achieving and maintaining weight loss

Wegovy® is a higher-dose version of Semaglutide specifically approved for chronic weight management in adults. It works by suppressing appetite and is administered via a weekly injection.

Benefits:

  • Significantly aids in weight loss
  • Reduces appetite
  • Supports long-term weight management

Individual results vary. All medications are prescribed only after medical evaluation, and ongoing monitoring is provided throughout treatment.

Schedule A Consultation

If you are interested in learning more about our weight loss program and how these medications can help you achieve your goals, please schedule a consultation with Dr. Sean Satey today. Our team is dedicated to providing personalized care and support throughout your weight loss journey.

In some cases, your provider may determine that a compounded medication is clinically appropriate based on your individual needs. When prescribed, compounded medications are offered on a self-pay basis. Compounded medications are not FDA-approved and are prepared by state-licensed pharmacies based on a provider’s clinical judgment.

FAQ

What Is the Difference Between Mounjaro, Zepbound, and Tirzepatide?

Mounjaro and Zepbound are the brand-name, FDA-approved medications. Some pharmacies may offer compounded tirzepatide when clinically appropriate. Compounded medications are not FDA-approved. Compounded tirzepatide is a non-FDA-approved formulation.

How Do Ozempic and Semaglutide Differ?

Ozempic is the FDA-approved brand product for blood sugar management and is often used off-label for weight loss. Compounded semaglutide is a non-FDA-approved formulation that may be available from certain pharmacies when medically appropriate.